New artificial intelligence tool may help personalize ovarian cancer treatment from day one

Researchers from the University of Minnesota Medical School, in collaboration with Emory University and the Georgia Institute of Technology, have developed a new artificial intelligence (AI) biomarker tool that may help predict how ovarian cancer patients will respond to treatment at the time of diagnosis.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup